Subscribe to our Newsletters !!
Whether in a peaceful corner of a suburban backyar
Biopharma plants run on tight schedules, so every
Dr. Mohammed Enayat’s recent testimony on his ag
The life science group Sartorius has successfully
Unlike other medications, Vyvanse (Lisdexamfetamin
Since it’s an ingredient in so many foods, you h
In our cover story, we shine a spotlight on “ The Magazine
Dr. Hemant R. Jadhav, a BITS Pilani professor, spends his days sketching tiny drug-like shapes on a computer screen and nights watching them grow into real compounds. His work targets cancer, HIV, Alzheimer’s, and diabetes—blending molecular design with hands-on testing to yield future-ready therapies.
At the core of his research are histone demethylases—epigenetic gatekeepers that control disease expression like a lock-and-key system. By combining in-silico predictions with experimental pharmacology, Dr. Jadhav is accelerating the drug discovery timeline.
Despite challenges in solubility, selectivity, and scalability, his multidisciplinary approach paves the way for smarter, more effective treatments.
Come prepared to think differently. This isn’t your usual lecture. Dr. Jadhav’s sharp insights make this a can’t-miss session—especially if you’re invested in the future of precision medicine.
